OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 15 filers reported holding OCUPHIRE PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,500 | +91263.6% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $110 | -99.8% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $68,000 | +17.2% | 30,000 | 0.0% | 0.00% | – |
| Q2 2022 | $58,000 | -29.3% | 30,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $82,000 | -8.9% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $90,000 | -29.1% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $127,000 | +2.4% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $124,000 | -13.3% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $143,000 | -55.6% | 30,000 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $322,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Regency Capital Management Inc.\DE | 15,000 | $79,000 | 0.06% |
| Ikarian Capital, LLC | 119,551 | $632,000 | 0.05% |
| NORRIS PERNE & FRENCH LLP/MI | 78,909 | $417,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,445 | $124,000 | 0.02% |
| Stokes Family Office, LLC | 12,120 | $64,000 | 0.01% |
| MARSHALL WACE, LLP | 329,131 | $1,738,000 | 0.01% |
| Cornerstone Capital, Inc. | 11,357 | $60,000 | 0.01% |
| MCF Advisors LLC | 9,499 | $50,000 | 0.01% |
| Cutler Group LLC / CA | 7,900 | $41,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,389 | $71,000 | 0.00% |